Antidiabetic Activity of Zinc Oxide and Silver Nanoparticles on Streptozotocin-Induced Diabetic Rats

Zinc oxide nanoparticles show antidiabetic activity in streptozotocin-induced Type 1 and 2 diabetic rats

(2013) Rinku D Umrani et al.   Nanomedicine

Current Concepts About Chromium Supplementation in Type 2 Diabetes and Insulin Resistance

(2010) Zhong Q. Wang et al.   Current Diabetes Reports

Zinc, zinc transporters and diabetes

(2010) J. Rungby   DIABETOLOGIA

Beta cell-specific Znt8 deletion in mice causes marked defects in insulin processing, crystallisation and secretion

(2010) N. Wijesekara et al.   DIABETOLOGIA

Prospective Study of Zinc Intake and Risk of Type 2 Diabetes in Women

(2009) Q. Sun et al.   DIABETES CARE

Current views on type 2 diabetes

(2009) Yi Lin et al.   JOURNAL OF ENDOCRINOLOGY

Zinc and diabetes — clinical links and molecular mechanisms

(2009) Judith Jansen et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Glycaemic control in type 2 diabetes: Targets and new therapies

(2009) Abd A. Tahrani et al.   PHARMACOLOGY & THERAPEUTICS

SLC30A3 Responds to Glucose- and Zinc Variations in ß-Cells and Is Critical for Insulin Production and In Vivo Glucose-Metabolism During ß-Cell Stress

(2009) Kamille Smidt et al.   PLoS One

Anti-inflammatory Properties of Cerium Oxide Nanoparticles

(2009) Suzanne M. Hirst et al.   Small

Evidence that the etiology of the syndrome containing type 2 diabetes mellitus results from abnormal magnesium metabolism

(2008) Ibert C. Wells   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Zinc supplementation for the treatment or prevention of disease: Current status and future perspectives

(2008) Hajo Haase et al.   EXPERIMENTAL GERONTOLOGY

Vanadium treatment of type 2 diabetes: A view to the future

(2008) Katherine H. Thompson et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Extracellular ATP and zinc are co-secreted with insulin and activate multiple P2X purinergic receptor channels expressed by islet beta-cells to potentiate insulin secretion

(2008) Clintoria Richards-Williams et al.   Purinergic Signalling

Zinc signalling and subcellular distribution: emerging targets in type 2 diabetes

(2008) Eugenio Mocchegiani et al.   TRENDS IN MOLECULAR MEDICINE

Hepatic glucokinase activity is the primary defect in alloxan-induced diabetes of mice

(2007) Xuemei Zhang et al.   BIOMEDICINE & PHARMACOTHERAPY